loading-image
 

Subscribe to our Weekly Newsletter

   
 
 
 
 
 
 

TMEAD (Tuberculosis Monitoring Encouragement and Adherence Drive)

 
Sensedose Technologies Pvt. Ltd.
 
Last Updated On 11 April 2020
Product USP
  • Daily regime monitoring; avoiding interruptions in the treatment
  • Reduces defaulters
  • Analyzes patient data
  • Real time alerts for RNTCP staff, caregivers and patients
 
Quick Summary
Product Category
Healthcare
Price Range
5000-10000
Year Of Establishment
1940
Contact Name
Nishad Halkarni
Contact Number     8329835556
Contact Email    nhalkarni@gmail.com
Organisation Address
4th Floor Digital Impact Square, Ashoka Business Enclave Near Ashoka Medicover Hospital
Nasik
Maharashtra
422009
Product Description

TMEAD (Tuberculosis Monitoring Encouragement and Adherence Drive) is an Initiative by Sensedose Technologies Pvt. Ltd. It offers a technology solution aimed at enhancing adherence to the Revised National TB Control Program (RNTCP) regimes, which helps in daily regime monitoring, avoiding interruptions in the treatment, reducing defaulters and analyzing patient data. Apart from helping patients to keep their daily regime in place, TMEAD eases work for Tuberculosis Health Visitors(TBHV) who needs to meet the challenge of tracking whether patient has taken the medicine or not.


About Sensedose Technologies Pvt. Ltd.

Sensedose technologies is a healthcare startup that is working hand in hand with the public healthcare system to achieve the goal set by Hon. PM Narendra Modi, of eliminating TB by2025, and the global goal of Ending Tuberculosis by 2030. Sensedose platform brings complete TB ecosystem right from patient, caregivers, last-mile public healthcare executives and state TBofficers on a single platform. It facilitates real-time flow of vital patient care information and medication adherence data to all the stakeholder for taking an informed decision.

 

Sensedose is improving treatment outcomes for tuberculosis by ensuring, the patients follow their medication regimen and complete it in time. While the average adherence rate was 62%, which is inadequate compared to the target of 85% Adherence rate that is required to meet global goals of eliminating Tuberculosis, Sensedose has achieved an adherence rate of 92% after deploying their platform in Nashik.

 

For more information, please visit Link

Why should a corporate partner with this Organization ?

Touched the lives of more than 250 patients. Nearly 27 patients have completed their medication regimen using the intervention and are now fully cured and living normal lives.

Using  IoT based solution, the existing adherence rate of 65% have grown to 98%


CSR projects of product

TMEAD (Tuberculosis Monitoring Encouragement and Adherence Drive)
Project Type: CSR
TMEAD introduces a ICT (Information Communication technology) based Intervention in the governments ....
 
More CSR Info >>

Other products

5ec796f3417d2.png

NT-Mask

Accelerating Growth of New India's Innovation (AGNIi)
5ec7806669152.png

Portable multi-feed oxygen supply ventilator (PMOSV-4)

Accelerating Growth of New India's Innovation (AGNIi)
5ec7771db509c.png

Face-shields

Accelerating Growth of New India's Innovation (AGNIi)
5ec625d133633.png

Face Shield

Jem world
5ec61a4555614.png

Face Mask

Jem world
 

Explore Organizations